|1.||Song, Jianrui: 1 article (01/2015)|
|2.||Li, Wei: 1 article (01/2015)|
|3.||Li, Tao: 1 article (01/2015)|
|4.||Wu, Ke: 1 article (01/2015)|
|5.||Meda, C: 1 article (05/2010)|
|6.||Uboldi, P: 1 article (05/2010)|
|7.||Arnaboldi, L: 1 article (05/2010)|
|8.||Catapano, A L: 1 article (05/2010)|
|9.||Corsini, A: 1 article (05/2010)|
|10.||Ferrarese, C: 1 article (05/2010)|
08/01/1984 - "Hepatic microsomes prepared from liver biopsy specimens obtained from a subject with cerebrotendinous xanthomatosis produced three times more 4-cholesten-3-one than the controls. "
08/01/1984 - "In other studies, the in vitro formation of 4-cholesten-3-one from cholesterol was measured in hepatic microsomal fractions prepared from a subject with cerebrotendinous xanthomatosis and from 3 control individuals. "
08/01/1984 - "The increased production of cholestanol in cerebrotendinous xanthomatosis may be accounted for by enhanced hepatic formation of 4-cholesten-3-one. "
12/01/1985 - "It was recently proposed that the increased biosynthesis of cholestanol in cerebrotendinous xanthomatosis (CTX) is due to increased activity of the delta 5-3 beta-hydroxysteroid dehydrogenase involved in bile acid biosynthesis, causing increased conversion of cholesterol into cholestanol through 4-cholesten-3-one. "
08/01/1984 - "Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis."
01/01/2015 - "Cholest-4-en-3-one has positive uses against obesity, liver disease, and keratinization. "
08/18/1998 - "Based on the findings that cholest-4-en-3-one, an intestinal metabolite of cholesterol, has an anti-obesity effect on animals, the structure-effect relationship of its 3-oxo derivatives and related compounds were investigated. "
10/01/1993 - "An anti-obesity effect was observed for cholest-4-en-3-one (cholestenone) which is an intestinal catabolite of cholesterol. "
10/01/1993 - "Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol, on mice."
|4.||Liver Diseases (Liver Disease)
|5.||Colonic Neoplasms (Colon Cancer)
|4.||3-Hydroxysteroid Dehydrogenases (3 beta Hydroxysteroid Dehydrogenase)
|6.||Bile Acids and Salts (Bile Acids)